Apimeds Pharmaceuticals US, Inc. (APUS)
NYSE: APUS · Pharmaceutical Preparations · Matawan, NJ · filing with the SEC since 2024
Who runs Apimeds Pharmaceuticals US, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Emerson Erik C.
Chief Executive Officer. First filing May 2025, latest Oct 17, 2025, 0 filings in all.
Officers reporting now
2
of 7 people with a filing in the last fifteen months
Directors reporting now
5
8 people on the record since 2025
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Emerson Erik C. | Chief Executive Officer | May 2025 | Oct 17, 2025 | none |
| Kim Christopher | Chairman and CMO | May 2025 | Oct 17, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kogan Elona | director | May 2025 | Nov 13, 2025 | none |
| Koo Jakap | director | May 2025 | Nov 13, 2025 | none |
| O'Donnell Carol A | director | May 2025 | Nov 13, 2025 | none |
| Weintraub Bennett | director | May 2025 | Nov 13, 2025 | none |
| Yoon Hankil | director | May 2025 | Nov 13, 2025 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Inscobee Inc. | 10% owner | May 2025 | Nov 21, 2025 | none |
Earlier names on the record1, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.